Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Sale | -$2.28M | -12.5K | -0.2% | $182.83 | 6.14M | Jul 16, 2021 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Sale | -$261K | -1.44K | -0.02% | $181.11 | 6.14M | Jul 19, 2021 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.605 to $184.48. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.235. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |